Indication

Helicobacter pylori gastritis

*Helicobacter pylori* gastritis is an infectious inflammatory disorder of the gastric mucosa caused by colonization with the microaerophilic, gram-negative bacterium *Helicobacter pylori*. Read more about Helicobacter pylori gastritis

325 drugs 142 manufacturers

Advertisement

Drugs that treat it

Common Helicobacter pylori gastritis therapies.

Showing 109–117 of 325 drugs

CLARITHROMYCIN

MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
Lannett Company

OMEPRAZOLE

ZOLLINGER-ELLISON SYNDROME·+10
CITRON PHARMA L

CLARITHROMYCIN

DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
ROXANE/WEST-WAR

AMOXICILLIN

BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+28
BI-COASTAL PHAR
Filter & compare in the drug finder →Opens the drug finder with Helicobacter pylori gastritis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Helicobacter pylori gastritis.

*Helicobacter pylori* gastritis is an infectious inflammatory disorder of the gastric mucosa caused by colonization with the microaerophilic, gram-negative bacterium *Helicobacter pylori*.

Primarily affecting the gastrointestinal system, it is widespread across global pediatric and adult populations, often persisting indefinitely if untreated.

Pathophysiologically, bacterial virulence factors and urease production promote mucosal injury and stimulate a chronic inflammatory response marked by neutrophilic and mononuclear epithelial infiltration.

While frequently asymptomatic, the condition can present with dyspepsia or epigastric discomfort and may progress to mucosal atrophy, intestinal metaplasia, peptic ulcer disease, or gastric malignancy.

Personalize your experience

Follow Helicobacter pylori gastritis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it